Home Rankings Most Stable Biotech Companies
Ranking · Stability

Most Stable Biotech Companies

Ranked by peer-relative stability score. Biotech companies with the most consistent financial profiles.

In the Healthcare segment, this ranking covers 22 companies, with visible stability scores ranging from 77 at the top to 3 at the lower end of the displayed cohort. The middle of the ranking sits around 48, so names materially above that level stand out on stability.

22 companies · Updated 2026-04-05
# Company Stability score
#1
ARGX.BR · Healthcare
77
#2
VRTX · Healthcare
76
#3
RPRX · Healthcare
75
#4
INCY · Healthcare
73
#5
UCB.BR · Healthcare
67
#6
TUB.BR · Healthcare
66
#7
REGN · Healthcare
65
#8
EXEL · Healthcare
65
#9
ALNY · Healthcare
53
#10
ROIV · Healthcare
53
#11
IONS · Healthcare
48
#12
ALK-B.CO · Healthcare
48
#13
INSM · Healthcare
44
#14
JAZZ · Healthcare
44
#15
BMRN · Healthcare
42
#16
GMAB.CO · Healthcare
40
#17
SMMT · Healthcare
37
#18
ZEAL.CO · Healthcare
36
#19
BAVA.CO · Healthcare
30
#20
RVMD · Healthcare
29
#21
ABVX.PA · Healthcare
24
#22
MRNA · Healthcare
3
Compare top companies from this ranking

Direct peer comparisons for the companies ranked above.

Interactive analysis in AssetNext

Full peer comparison, portfolio integration and live data for all ranked companies.

Open AssetNext →
Browse company analyses

Rankings based on peer-relative stability scores. Descriptive only — not investment advice. Scores reflect structural position within each company's functional peer group.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.